rifabutin (Lupin Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the rifabutin drug offered from Lupin Pharmaceuticals, Inc.. This Rifamycin Antimycobacterial [EPC],Rifamycins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Lupin Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | rifabutin |
SUBSTANCE NAME: | RIFABUTIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Rifamycin Antimycobacterial [EPC],Rifamycins [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-03-26 |
END MARKETING DATE: | 0000-00-00 |
rifabutin HUMAN PRESCRIPTION DRUG Details:
Item Description | rifabutin from Lupin Pharmaceuticals, Inc. |
LABELER NAME: | Lupin Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2014-03-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68180-285_9df90e3e-1e87-45d5-9fa9-74d44f371128 |
PRODUCT NDC: | 68180-285 |
APPLICATION NUMBER: | ANDA090033 |
Other RIFABUTIN Pharmaceutical Manufacturers / Labelers: